Medicrea disclosed Chairman and CEO Denys Sournac purchasing company shares.
Here are three points:
1. Mr. Sournac acquired 90,045 shares between Jan. 22 and Jan. 25.
2. Medicrea focuses on devolving products for personalized spine surgery, based on a data-driven and system-based approach.
3. The company develops spinal implant technologies that surgeons have used in 150,000-plus procedures.